The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
S3Xrw5h1Sm6AyAq3
